Government to certify computer hackers
Licensed to hack? That’s the new plan from the government’s National Cyber Bureau, which has issued a new policy statement called “Regulation of Cyber Protection Professionals in Israel.” The bureau is creating a category of government-approved hacker who can be employed by the state or entities providing critical infrastructure to help protect computer networks against criminal hackers. Private companies, however, won’t be required to hire approved hackers. “Today, different organizations employ professionals in cyber defense in a wide range of disciplines, with a big difference in their level of professionalism and without any certainty that they meet professional standards,” the bureau explained. The bureau will keep a register of approved hackers, with designations ranging from cyber security practitioner (the most junior level of certification) to cyber security technology expert, the most senior. First examinations will be given next year, with some exemptions for people with pre-existing educational qualifications, the bureau said. (Amitai Ziv)
InSightec raises $22 million, names new CEO
InSightec, which makes noninvasive surgical equipment based on a high-intensity ultrasound beam to heat and destroy targeted tissue, said Sunday it had raised $22 million, and that Maurice R. Ferré would replace founder Kobi Vortman as CEO. The company said the capital came from new and existing investors, whom it didn’t name, and would give them a 7.3% stake in the company. In addition, U.S. firm General Electric sold a 13% stake it held in InSightec to fellow shareholders and gave them an option to buy another 4% within the next two years. Ferré was chairman and CEO of Mako Surgical, a Miami-based maker of robotic-surgical technology he founded in 2004 and sold to Stryker Corporation for $1.65 billion in 2013. Vortman founded InSightec in 1999 to develop Magnetic Resonance-guided Focused Ultrasound technology. The technology, which won its first U.S. approval in 2004, has been used to treat the human brain through an intact skull. (TheMarker).
Pi-Cardia secures $10m for heart-valve technology
Pi-Cardia, which has developed a novel technology for treating patients with aortic valve stenosis without implants, said yesterday it had secured $10 million in new funding. It said the round included a new, unnamed strategic investor, as well as the Italian funds Innogest and Fondo Atlante Ventures, and China’s VI-Ventures. Existing investors in the company, including Clal Biotechnology and Anatomy Medical Technology Fund, also joined the round. Formed in 2009, Pi-Cardia’s Leaflex Catheter System fractures heart-valve calcification, thereby avoiding the need to implant a new valve. Last year, Pi-Cardia successfully completed enrolling its first set of patients for a study in Europe, demonstrating safety and feasibility of the procedure. The new funds will allow the company to complete the development of a second-generation device and continue the clinical studies, with the aim of obtaining a European CE-Mark that would allow it to sell the device. (TheMarker)